CFDE Data Portal | Search COMP

	Label	Description
	COMP Gene (Entity type)	ENSG00000105664 - cartilage oligomeric matrix protein
	COMP associations Collection (Entity type)	Associations for COMP_associations
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 0 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 5 V 10 PREDNISOLONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 2 V 7 PIRFENIDONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE224311 3 V 4 CHAETOCIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	COMP associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE125014 enzalutamide prostate gland 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

COMP

ENSG00000105664 - cartilage oligomeric matrix protein

COMP associations

Associations for COMP_associations

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE172016 2 V 0 PACLITAXEL HUMAN DN

A Gene Set from LINCS

GSE164874 5 V 10 PREDNISOLONE HUMAN DN

A Gene Set from LINCS

GSE226249 2 V 7 PIRFENIDONE HUMAN UP

A Gene Set from LINCS

GSE224311 3 V 4 CHAETOCIN HUMAN UP

A Gene Set from LINCS

COMP associations.tsv

A file from IDG as part of the Harmonizome project

GSE125014 enzalutamide prostate gland 1 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.